Ligand Pharma Directors Trade 4,000 Shares in Quick Buy‑Sell Swirl – No Big Shake‑Up Expected.
Insider trades at Ligand reveal routine portfolio rebalancing, not a shift in confidence. Watch for future moves that could hint at price upside.
3 minutes to read
